Rifampin-induced pseudomembranous colitis with rectosigmoid sparing
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yim S.Y. | - |
dc.contributor.author | Koo J.S. | - |
dc.contributor.author | Kim Y.J. | - |
dc.contributor.author | Park S.J. | - |
dc.contributor.author | Kim J.N. | - |
dc.contributor.author | Jung S.W. | - |
dc.contributor.author | Yim H.J. | - |
dc.contributor.author | Lee S.W. | - |
dc.contributor.author | Choi J.H. | - |
dc.contributor.author | Kim C.D. | - |
dc.date.available | 2020-11-03T04:45:29Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 2234-2400 | - |
dc.identifier.issn | 2234-2443 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/14035 | - |
dc.description.abstract | Pseudomembranous colitis (PMC) is known to be associated with antibiotic treatment, but is not commonly related to antitubercular (anti-TB) agent, rifampin. PMC is frequently localized to rectum and sigmoid colon, which can be diagnosed with sigmoidoscopy. We report a case of rifampin-induced PMC with rectosigmoid sparing in a pulmonary tuberculosis patient. An 81-year-old man using anti-TB agents was admitted with a 30-day history of severe diarrhea and general weakness. On colonoscopy, nonspecific findings such as mucosal edema and erosion were found in sigmoid colon, whereas multiple yellowish plaques were confined to cecal mucosa only. Biopsy specimen of the cecum was compatible with PMC. Metronidazole was started orally, and the anti-TB medications excluding rifampin were readministerred. His symptoms remarkably improved within a few days without recurrence. Awareness of rectosigmoid sparing PMC in patients who develop diarrhea during anti-TB treatment should encourage early total colonoscopy. © 2011 The Korean Society of Gastrointestinal Endoscopy. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | Rifampin-induced pseudomembranous colitis with rectosigmoid sparing | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.5946/ce.2011.44.2.137 | - |
dc.identifier.scopusid | 2-s2.0-84878719940 | - |
dc.identifier.bibliographicCitation | Clinical Endoscopy, v.44, no.2, pp 137 - 139 | - |
dc.citation.title | Clinical Endoscopy | - |
dc.citation.volume | 44 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 137 | - |
dc.citation.endPage | 139 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001624274 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Antitubercular agent | - |
dc.subject.keywordAuthor | Colonoscopy | - |
dc.subject.keywordAuthor | Enterocolitis | - |
dc.subject.keywordAuthor | Pseudomembranous | - |
dc.subject.keywordAuthor | Rifampin | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.